Portfolio (Quarterly)
Guide ↗
Propel Bio Management, LLC
· CIK 0001969764| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | PAGP | PLAINS GP HLDGS L P | Energy | 1,272,360.0 | $30.2M | 19.02% | — | — | $23.72 | +7.5% |
| 2 | — | ACHIEVE LIFE SCIENCES INC | — | 3,786,425.0 | $11.4M | 7.17% | — | — | $3.00 | — |
| 3 | PHAT | PHATHOM PHARMACEUTICALS INC | Healthcare | 841,272.0 | $9.4M | 5.90% | +100K | +13.5% | $11.12 | -0.2% |
| 4 | DCTH | DELCATH SYS INC | Healthcare | 979,698.0 | $9.2M | 5.77% | +541K | +123.4% | $9.35 | +15.8% |
| 5 | CORT | CORCEPT THERAPEUTICS INC | Healthcare | 147,828.0 | $6.0M | 3.80% | NEW | — | $40.74 | +48.2% |
| 6 | — | ABEONA THERAPEUTICS INC | — | 1,329,899.0 | $6.0M | 3.79% | +499K | +60.1% | $4.52 | — |
| 7 | VOR | VOR BIOPHARMA INC | Healthcare | 314,543.0 | $5.6M | 3.52% | NEW | — | $17.76 | -20.6% |
| 8 | KYTX | KYVERNA THERAPEUTICS INC | Healthcare | 644,421.0 | $5.6M | 3.52% | -22K | -3.3% | $8.67 | -0.7% |
| 9 | MIST | MILESTONE PHARMACEUTICALS IN | Healthcare | 4,118,321.0 | $5.1M | 3.20% | — | — | $1.23 | +13.5% |
| 10 | CLDX | CELLDEX THERAPEUTICS INC NEW | Healthcare | 131,364.0 | $4.1M | 2.61% | -23K | -14.9% | $31.48 | -2.0% |
| 11 | CMPS | COMPASS PATHWAYS PLC | Healthcare | 742,049.0 | $4.1M | 2.60% | -120K | -13.9% | $5.55 | +120.3% |
| 12 | VRDN | VIRIDIAN THERAPEUTICS INC | Healthcare | 210,163.0 | $4.1M | 2.58% | -72K | -25.6% | $19.45 | -12.6% |
| 13 | IVA | INVENTIVA SA | Healthcare | 724,678.0 | $4.0M | 2.52% | -275K | -27.5% | $5.51 | -6.4% |
| 14 | — | SAB BIOTHERAPEUTICS INC | — | 1,012,790.0 | $3.9M | 2.45% | +360K | +55.1% | $3.84 | — |
| 15 | OBIO | ORCHESTRA BIOMED HLDGS INC | Healthcare | 896,701.0 | $3.8M | 2.41% | NEW | — | $4.27 | -7.1% |
| 16 | FDMT | 4D MOLECULAR THERAPEUTICS IN | Healthcare | 380,420.0 | $3.6M | 2.26% | NEW | — | $9.41 | -7.5% |
| 17 | — | OCULIS HOLDING AG | — | 122,223.0 | $3.3M | 2.07% | -51K | -29.3% | $26.83 | — |
| 18 | OCUL | OCULAR THERAPEUTIX INC | Healthcare | 382,375.0 | $3.2M | 2.03% | NEW | — | $8.44 | -1.7% |
| 19 | — | UPSTREAM BIO INC | — | 341,779.0 | $3.1M | 1.95% | NEW | — | $9.07 | — |
| 20 | AQST | AQUESTIVE THERAPEUTICS INC | Healthcare | 710,988.0 | $3.0M | 1.86% | NEW | — | $4.15 | -1.7% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
75.4%
Energy
24.6%